세계의 엑소좀 진단, 치료, 연구 툴 시장

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

The global market for research tools and reagents in exosome diagnostics, therapeutics and research tools is estimated to increase from $137.2 million in 2023 to reach $352.7 million by 2028, at a CAGR of 20.8% from 2023 through 2028.

The global market for diagnostics and monitoring in exosome diagnostics, therapeutics and research tools is estimated to increase from $90.3 million in 2023 to reach $654.3 million by 2028, at a CAGR of 48.6% from 2023 through 2028.

Report Scope

This report aims to provide a comprehensive study of the global market for exosome diagnostic, therapeutic, and research tools, both in terms of quantitative and qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding exosome products. BCC Research estimates market data for 2022 (the base year) and forecasts values for 2023 through 2028.

The scope of this study is global and covers exosome products and research tools used in the healthcare industry only. Exosome products and research tools used in other sectors, such as skincare and beauty, are beyond the scope of this report.

Report Includes

• 14 data tables and 77 additional tables
• Analysis of the global markets and global trends for exosome diagnostics and therapeutics, with revenue data for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
• Estimate of the current market size and revenue growth prospects, along with a market share analysis based on product, application, end user and region
• Facts and figures pertaining to the market drivers, opportunities and restraints, and the impacts of macroeconomic variables
• Discussion of emerging technologies, regulations and R&D efforts
• Evaluation of new commercial opportunities in the diagnostics, therapeutics and research tools markets, and an assessment of trends, products and assay developments
• Insight into the use of exosome proteins and nucleic acids as diagnostic biomarkers and their impact on the microRNA, liquid biopsy and stem cell research industry
• Analysis of relevant patents related to exosome diagnostics and therapeutics in the U.S., Europe and Japan
• Overview of sustainability trends and ESG developments, including consumer attitudes, companies' ESG score rankings and their ESG practices
• Analysis of the competitive landscape, including companies' market shares, business segments, financials and product portfolios, as well as recent M&A activity and a venture funding outlook
• Company profiles of major players within the industry, including Bio-Techne, Exosomics S.p.A., and System Biosciences LLC.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Exosome Basics
• Exosome Biogenesis and Processing
• Exosome Function and Physiology
• Intracellular Communication
• Facilitation of the Immune Response
• Tissue Regeneration
• Bioinformatic Databases for Exosome Research and Product Development
• ExoCarta
• Vesiclepedia
• EVpedia

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Increasing Investment in Biomedical Research
• Trend Towards Precision Medicine
• Technological Advancements in Exosome Research Tools
• Restraints
• Evolving Regulatory Landscape
• Lack of Well-Characterized Exosome Standards
• Opportunities
• Growing Popularity in Liquid Biopsy
• Benefits Over Stem Cell Therapy
• Challenges
• Funding Issues

Chapter 4 Regulatory Landscape

• U.S.
• Exosome Therapeutics
• Exosome Clinical Assays Development and Marketing

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies
• Engineered Exosomes
• Microfluidic Technology
• Exosome Research Services
• Exosome Based Liquid Biopsy Tests
• Clinical Trial Analysis
• Overview
• By Phases
• By Funder Type
• By Disease Type
• By Country
• Pipeline Analysis

Chapter 6 Market Segmentation Analysis

• Segmental Breakdown
• Market Analysis by Application Type
• Diagnostics and Monitoring
• Evaluation of the Diagnostics and Monitoring Market
• Cancer
• CNS Disorders and Neurodegeneration Diseases
• Organ Transplantation
• Cardiovascular Diseases
• Others
• Diagnostics and Monitoring Market Revenue
• Exosome Therapeutics
• Potential Therapeutic Applications
• Evaluation of the Current and Potential Therapeutics Market
• Key Target Indications
• Research Tools and Regents
• Research Tools and Reagents Market Revenue
• Geographic Breakdown
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 7 Competitive Intelligence

• Overview
• Exosome-Based Clinical Diagnostics Market
• Market Participants in the Exosome-Based Clinical Diagnostics Market
• Exosome-Based Therapeutics Market
• Market Participants in the Exosome-Based Therapeutics Market
• Exosome Research Tools and Reagents Market
• Market Participants in the Exosome Research Tools and Reagents Market
• Key Strategies
• Opportunities and Challenges in the Exosome Market

Chapter 8 Appendix

• Methodology
• Sources/References
• Acronyms
• Company Profiles
• ACOUSORT AB
• AEGLE THERAPEUTICS
• AETHLON MEDICAL INC.
• ARUNA BIO INC.
• BIO-TECHNE
• CAPRICOR THERAPEUTICS INC.
• CARIS LIFE SCIENCES
• DIRECT BIOLOGICS LLC
• EXOSOMICS SPA
• EVOX THERAPEUTICS LTD.
• KIMERA LABS
• LONZA
• MIR SCIENTIFIC
• NANO MED
• NANOSOMIX
• RION
• SYSTEM BIOSCIENCES LLC